U. Shah. GPR119 agonists: A promising new approach for the treatment of type 2 diabetes and related metabolic disorders.
Current Opinion in Drug Discovery and Development, 2009, 12, 4, p. 519-532.
Код: Выделить всё
http://www.biomedcentral.com/1367-6733/12/519
